Search
Search Results
##search.searchResults.foundPlural##
-
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3509PDF: 2387HTML: 1446 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
8989PDF: 6031HTML: 87929Fig.1b: 179Fig.1c: 182Fig.2a: 172Fig.2b: 171Fig.4: 184Fig.2c: 179Fig.3: 178Tab.1: 223Tab.2: 203Tab.3: 185Tab.4: 218Fig1a: 177 -
ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
2810PDF: 1214HTML: 2686Figure 1: 166 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3339PDF: 1271HTML: 2207Fi.1 Gritti.Rambaldi: 201 -
Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India
3161PDF: 767HTML: 2935Figure 1a and 1b: 144Figure 2: 154Figure 3: 173Figure 4: 155Figure 5: 159Tables 1-5: 150 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4026PDF: 1915HTML: 5211Table 1: 182 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4280PDF: 1474HTML: 1539Untitled: 221 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2261PDF: 1316HTML: 17069Bassan Fig.1: 138Bassan Fig.2: 149Bassan Fig.4: 136Fig.3: 177 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4018PDF: 3319HTML: 192 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
1668PDF: 750HTML: 482 -
BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL
1597PDF: 1083HTML: 109 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1363PDF: 812HTML: 3111 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2570PDF: 1600HTML: 2346Table1: 187 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1261PDF: 605HTML: 3068 -
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES
2143PDF: 1988HTML: 165 -
ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication
2353PDF: 992HTML: 1639Fig 1: 177Tab I: 205Cover Letter: 199 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3710PDF: 1456HTML: 475Figures . Eliassian: 215 -
HODGKIN LYMPHOMA IN CHILDREN: A 16-YEAR EXPERIENCE AT THE CHILDREN’S WELFARE TEACHING HOSPITAL OF BAGHDAD, IRAQ
1016PDF: 917Suppl. Files: 588HTML: 77 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1230PDF: 469HTML: 18555Figure 1: 163Figure 2: 145Figure 3: 164Figure 4: 199Figure 5: 171 -
AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC LEUKEMIA: NON-RANDOMIZED STUDY WITH A MAXIMUM FOLLOW-UP OF MORE THAN 22 YEARS
1518PDF: 896HTML: 1945Figure: 167Tables: 183ALL revision 1: 188response to reviewer: 178 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3491PDF: 1538HTML: 69 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2136PDF: 1455HTML: 258 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1150PDF: 599HTML: 6790 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2007PDF: 812HTML: 206 -
EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES
2168PDF: 791HTML: 1620Figure 1: 176Table 1: 197 -
OLDER ADULTS WITH PH NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A MONOCENTRIC EXPERIENCE ON CONSECUTIVE PATIENTS AGED MORE THAN 55 YEARS Older Adults with Ph Negative Acute Lymphoblastic Leukemia
1276PDF: 557Suppl. Files: 341HTML: 135 -
CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL
1232PDF: 477HTML: 131 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1537PDF: 596HTML: 180 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
1805PDF: 708HTML: 2094Untitled: 205Untitled: 149Untitled: 166Untitled: 150Untitled: 158Untitled: 173Untitled: 181 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2059PDF: 982HTML: 4062Cover Letter: 217Figure 1: 224Figure 2: 225Table 1: 200







